Perseus Proteomics Inc. (4882.T)
JPY 610.0
(-0.65%)
JPY 610.0
(-0.65%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.69 Billion JPY | -34.01% |
| 2022 | 2.56 Billion JPY | -22.24% |
| 2021 | 3.3 Billion JPY | 195.05% |
| 2020 | 1.11 Billion JPY | 104.5% |
| 2019 | 547 Million JPY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 2.2 Billion JPY | 30.3% |
| 2023 Q2 | 1.98 Billion JPY | -7.56% |
| 2023 Q4 | 1.69 Billion JPY | -5.72% |
| 2023 Q3 | 1.79 Billion JPY | -9.71% |
| 2023 FY | 1.69 Billion JPY | -34.01% |
| 2023 Q1 | 2.15 Billion JPY | -16.13% |
| 2022 Q3 | 2.74 Billion JPY | -5.0% |
| 2022 FY | 2.56 Billion JPY | -22.24% |
| 2022 Q4 | 2.56 Billion JPY | -6.5% |
| 2022 Q2 | 2.88 Billion JPY | 0.0% |
| 2021 FY | 3.3 Billion JPY | 195.05% |
| 2020 FY | 1.11 Billion JPY | 104.5% |
| 2019 FY | - JPY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Kyowa Kirin Co., Ltd. | 1025.94 Billion JPY | 99.835% |
| Astellas Pharma Inc. | 3569.6 Billion JPY | 99.953% |
| Chugai Pharmaceutical Co., Ltd. | 1932.54 Billion JPY | 99.912% |
| Ono Pharmaceutical Co., Ltd. | 913.66 Billion JPY | 99.815% |
| Santen Pharmaceutical Co., Ltd. | 435.69 Billion JPY | 99.611% |
| JCR Pharmaceuticals Co., Ltd. | 102.22 Billion JPY | 98.343% |
| Daiichi Sankyo Company, Limited | 3461.13 Billion JPY | 99.951% |
| Otsuka Holdings Co., Ltd. | 3361.24 Billion JPY | 99.95% |